• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)

$3,995.00 – $7,990.00

Clear
SKU: KLI15600856 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Pages: 450
  • Description
  • Table of Contents
  • Latest reports

Description

What is the Size of the Point of Care Diagnostic Testing Market?

 
This report provides an in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will be part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.

Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics.

  • POC Glucose Testing
  • POC Infectious Disease Testing, (including Hepatitis, HIV, Respiratory and Others)
  • POC Cancer Tumor Marker Testing
  • POC Colon Cancer Testing
  • POC Electrolytes and Blood Testing
  • POC Substance Abuse Testing
  • POC Pregnancy and Fertility Testing
  • POC Cardiac Markers
  • POC Urine Testing
  • Other POC Testing
  • Products on the Market
  • Company Profiles 

An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will be part of a paradigm shift from curative medicine to predictive, personalized and preemptive medicine.

Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics.

The menu for point-of-care testing continues to expand. The traditional set of POC tests includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

In the past 5-10 years the following tests were added: HgA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time more, decentralized test venues invest in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record.

Where are Point of Care Tests Winning?

Molecular POC tests in physician office are already available for respiratory infections and more. The capacity to provide precise answers for time sensitive tests such as sexually transmissible diseases and other infections will drive the market for POC molecular test devices. Ease of use is a plus for hospital labs. Worldwide, lab budgets are being cut for test send-outs and there are not enough trained technologists to run molecular tests in their present configuration.

A major factor in achieving this goal of more precise and personalized therapeutic options is the use of advanced algorithm driven information technologies that can turn test data into actionable medical decision-making information. This trend is driven by the involvement of major information technology companies and payers that are tired of paying for drugs that often have limited positive patient outcome.

Information about diseases, therapies and tests is readily available via the Internet and a growing number of apps on personal digital assistants (PDAs) including all sorts of smart phones. Wearable devices participate in this area by collecting vital sign data that are then analyzed by IT tools to provide health care improvement instructions.

These are among the companies covered in The Worldwide Market for Point of Care (POC) Testing Technologies


Who’s Competing in the Market for Point of Care Diagnostics?

Large and small companies are involved in the development and/or marketing of POC testing. The market is considered evolving with growth opportunity. Developing and developed markets alike have room to grow due to an aging population worldwide. Key companies such as Roche, LifeScan, Abbott /Alere and Siemens Healthineers will likely maintain leading positions in the market through continued product innovation and strategic alliances and mergers.

Among the top and/or innovative competitors discussed within Corporate Profiles are:

  • 1 Step Detect Associates
  • Abaxis
  • Abbott Labs
  • Abingdon Health
  • Access Bio
  • AccuBioTech Co
  • Accutech
  • Accriva Diagnostics
  • ACON Laboratories
  • Aerscher Diagnostics
  • Akers Biosciences
  • Alere
  • Alfa Scientific Designs
  • American Bio Medica
  • AmniSure
  • Aquila Diagnostic System
  • Arlington Scientific
  • Arkray
  • Artron Laboratories
  • Atlas Genetics
  • Atlas Link Biotech
  • Ativa Medical Corp
  • Audit Diagnostics
  • Autobio Diagnostics
  • Augurix Diagnostic
  • Axxin
  • Beckman Coulter
  • Becton Dickinson
  • Beijing Wantai Biological Pharmaceuticals
  • Bhat Bio-Tech India Private Ltd.
  • bioLytical Laboratories
  • Biomerica
  • biOracle Limited
  • BioMedomics
  • Biomeme
  • bioMerieux SA
  • Biophor Diagnostics
  • Bio-Rad Laboratories
  • Bioscan Screening Systems
  • Biotron Diagnostics
  • Biosensia
  • Boditech Med
  • Boson Biotech
  • BTNX
  • Calypte Biomedical Corp
  • CARE Products
  • Cepheid
  • Chembio Diagnostic Systems
  • Church & Dwight
  • Clarity Diagnostics
  • Confirm Biosciences
  • CTK Biotech
  • Daktari Diagnostics
  • Danaher Corporation
  • Dexcom
  • DIALAB
  • DiaSys Diagnostic Systems
  • Diaxohit
  • Diazyme Laboratories
  • DNA Electonics Ltd.
  • Dragerwerk AG
  • Dr Fooke-Achterrath
  • DRG International
  • Eiken Chemical
  • EKF Diagnostics
  • ELITechGroup, Inc
  • Enterix
  • Entopsis
  • Eurolyser Diagnostica
  • EY Laboratories
  • Exalenz Bioscience
  • FABPulous B.V.
  • Fio Corp
  • First Check Diagnostics
  • GenBio
  • Genedrive
  • GeTein BioMedical
  • GlysBy
  • Helena Labs
  • Hema Diagnostic System
  • Hemosure
  • HORBIA
  • Immunosciences Lab
  • InSilixa
  • Instrumentation Laboratory
  • JAL Innovations
  • Jant Pharmacal
  • J. Mitra & Co Pvt
  • LamdaGen Corp
  • LifeScan
  • LifeSign
  • Macherey-Nagel
  • Magnasense Technologies
  • Mbio Diagnostics
  • Medix Biochemica
  • MedMira
  • Medtronic
  • Menarini Diagnostics
  • Meridian BioScience
  • Metaara Medical Technologies
  • Micronics
  • Nano-Ditech Corporation
  • Noble Medical
  • Nova Biomedical
  • Oasis Diagnostics
  • Operon
  • OPKO Health
  • OPTI Medical Systems
  • OraSure Technologies
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • Polymedco
  • Polymer Technologies
  • Preventis
  • Princeton Biomeditech
  • QuantuMDx Group
  • Quidel
  • Radiometer Medical
  • RENESA UG
  • Response Biomedical
  • Reszon Diagnostics
  • Rheonix
  • Roche Diagnostics
  • Samsung Healthcare
  • Savyon Diagnostics
  • Sekisui Diagnostics
  • Siemens Healthcare
  • Siloam Biosciences
  • Spectral Medical
  • Sysmex
  • TECHLAB
  • Teco Diagnostics
  • Tosoh
  • Trinity Biotech
  • Trividia Health
  • Tulip Diagnostics
  • Veredus Laboratories
  • Vircell
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Werfen
  • Xagenic
FROM THE REPORT – Major Conclusions

Conclusion One – Paradigm shift toward prevention and early detection of disease

The development of smaller devices and Bluetooth communication has dramatically changed the patient/physician roles. Patients are more interested in playing a bigger role in their own healthcare. This will lead to more personalized healthcare with interventions tailored to specific patients.

Conclusion Two –POC Molecular Diagnostics continue to make inroads

Molecular POC diagnostics is at the nexus of low-complexity rapid testing performed near the patient and high-technology clinical molecular diagnostics. The emergent molecular POC test space seeks to leverage the key strengths of both segments – rapid results with ease of use operation and high sensitivity and specificity results – to address critical testing areas relating to emergency care, rapid clinical intervention, effective field screening, and the control of high-burden diseases in the developing world.

Conclusion Three- Technological progress is expanding the POC test market

Technological progress is expanding the domain of rapid and point-of-care tests. Led by the U.S. population, the global client base for POC products and tests (including physician offices and other primary care settings such as clinics and mobile labs) is significant – accounting for $19.5 billion in sales in 2017 – and will endure through episodes of healthcare expansion and reform found worldwide. However, the role of POC tests remains contentious due to questions regarding quality control or accuracy and added costs. In the United States, recent results of the GPA Waived Project have vindicated regulatory concerns regarding the quality of CLIA-waived testing that have also stalled the introduction of additional test waivers. Skepticism regarding POC test accuracy is significantly stronger abroad, with much more limited test menus for reimbursement or outright bans on testing at unaudited or uncertified office labs.

Table of Contents

1: EXECUTIVE SUMMARY

INTRODUCTION

SCOPE AND METHODOLOGY

SIZE AND GROWTH OF THE MARKET

Table 1-1: Global POC Test Market, 2015-2022 (in millions % at manufacturer level)

TRENDS AFFECTING THE MARKET

COMPETITIVE OUTLOOK

MARKET CONCLUSIONS

Conclusion One – Paradigm shift toward prevention and early detection of disease

Conclusion Two –POC Molecular Diagnostics continue to make inroads

Conclusion Three- Technological progress is expanding the POC test market

Conclusion Four – Test cost will continue to be an issue worldwide

Conclusion Five– Reimbursement and economic conditions will continue to be an issue

Conclusion Six – Rising demand will drive POC market in RoW markets

2: INTRODUCTION AND OVERVIEW

POINT-OF-CARE DIAGNOSTICS TESTING

INDUSTRY REGULATIONS

POC INDUSTRY DRIVERS

Patient focused drivers

Medical/Healthcare related drivers

Technology drivers

Economic drivers

Other drivers

POC TEST TYPES

Blood

Urine

Saliva

Hair

Optical Technologies

Breath

CONDITIONS EVALUATED BY POC DIAGNOSTIC TESTING

Cancer

Cardiovascular Disease

Diabetes

Drug Abuse

Central Nervous System Stimulants

Prevalence and Number of Illicit Drug Users

Table 2-1: Estimated Number and Prevalence of Drug Users by Region and Age (15-64)

Infectious Disease

Pregnancy and Fertility

3: POC BLOOD GLUCOSE TESTS

TYPES OF BLOOD GLUCOSE TESTING

Fasting Blood Sugar (FBS)

2-Hour Postprandial Blood Sugar (PPBS)

Random Blood Sugar

Glucose Tolerance Test

Glucose Urine Test

Glycated Hemoglobin (HbA1c)

PRODUCTS

Blood Glucose Self-Testing

Table 3-1: Selected Glucose Self-Test Meter Innovations

Table 3-2: Selected Apps and Glucose Management IT

Continuous Self-Testing

Glycated Hemoglobin Tests

Professional

MARKET SIZE AND GROWTH

Table 3-3: Global POC Glucose Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 3-1: POC Blood Glucose Testing Regional Market Analysis 2017

POC Glucose Self-Testing

Table 3-4: Global POC Glucose Self Testing Market (includes continuous glucose devices)

POC Glucose Professional Testing

Table 3-5: Global POC Glucose Professional Testing Market (includes HbA1c testing)

COMPETITIVE ANALYSIS

Table 3-6: Global POC Blood Glucose Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 3-2: Global POC Glucose Test Manufacturers by Percent, 2017

4: POC BLOOD AND ELECTROLYTES TESTING MARKET

TYPES OF BLOOD AND ELECTROLYTES TESTS

Hemoglobin/Hematocrit

WBC

Blood Gases

Electrolytes

PRODUCTS

Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2017

Table 4-2: Selected POC Hematology Analyzer Systems, 2017

Recent Developments

MARKET SIZE AND GROWTH

Table 4-3: Global POC Blood and Electrolytes Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 4-1: POC Blood and Electrolytes Testing Regional Market Analysis 2017

POC Blood and Electrolyte Self-Testing

POC Blood and Electrolyte Professional Testing

Table 4-4: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

COMPETITIVE ANALYSIS

Table 4-5: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers by Percent, 2017

5: POC RAPID COAGULATION

PRODUCTS

Table 5-1: Selected POC Coagulation Innovations

Platelet Testing

Table 5-2: Selected Platelet Activity Test Innovations

MARKET SIZE AND GROWTH

Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 5-1: POC Rapid Coagulation Testing Regional Market Analysis 2017

POC Rapid Coagulation Self-Testing

Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

POC Rapid Coagulation Professional Testing

Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2017-20220 (in millions of dollars at the manufacturer’s level)

COMPETITIVE ANALYSIS

Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions$)

Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share % of Leading Suppliers, 2017

6: POC RAPID CARDIAC MARKERS

PRODUCTS

MARKET SIZE AND GROWTH

Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 6-1: POC Rapid Cardiac Markers Testing Regional Market Analysis 2017

COMPETITIVE ANALYSIS

Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 6-2: Global POC Cardiac Test Manufacturers by Percent, 2017

7: POC SUBSTANCE ABUSE

PRODUCTS

Urine

Oral

Blood

Hair

MARKET SIZE AND GROWTH

Table 7-1: Global POC Drugs of Abuse Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 7-1: POC Substance Abuse Testing Regional Market Analysis 2017

POC Drugs of Abuse Self-Testing

Table 7-2: Global POC Drugs of Abuse Self Testing Market (includes continuous glucose devices)

POC Drugs of Abuse Professional Testing

Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

COMPETITIVE ANALYSIS

Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2017

Figure 7-2: Global POC Drug of Abuse Testing Manufacturers by Percent, 2016

8: POC PREGNANCY AND FERTILITY TESTING

PRODUCTS

Table 8-1: 2016 Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay

MARKET SIZE AND GROWTH

Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 8-1: POC Pregnancy and Fertility Testing Regional Market Analysis 2017

POC Pregnancy and Fertility Self-Testing

Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

POC Pregnancy and Fertility Professional Testing

Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2016-2021 (in millions of dollars at the manufacturer’s level)

COMPETITIVE ANALYSIS

Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers by Percent, 2017

9: POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING

PRODUCTS

Table 9-1: Selected POC Colon Cancer Tests

MARKET SIZE AND GROWTH

Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis: 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional Market Analysis 2017

POC Colon Cancer Screening/Fecal Occult Blood Self-Testing

Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing

Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

COMPETITIVE ANALYSIS

Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2016 (in millions $)

Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers by Percent, 2017

10: POC INFECTIOUS DISEASE TESTING

PRODUCTS

MARKET SIZE AND GROWTH

Table 10-1: Global POC Infectious Disease Testing Market Analysis: 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 10-1: POC Infectious Disease Testing Regional Market Analysis 2017

POC Infectious Disease Self-Testing

Table 10-2: POC Infectious Disease Self-Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

POC Infectious Disease Professional Testing

Table 10-3: POC Infectious Disease Professional Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

POC Infectious Disease Testing by Disease Type

Table 10-4 : Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type (in milliions $)

COMPETITIVE ANALYSIS

Table 10-5: Global POC Infectious Disease Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 10-2: Global POC Infectious Disease Test Manufacturers by Percent, 2017

11: POC LIPID TESTING

PRODUCTS

MARKET SIZE AND GROWTH

Table 11-1: Global POC Lipidl Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 11-1: POC Lipid Testing Regional Market Analysis 2017

POC Lipid Self-Testing

Table 11-2: POC Lipid Self-Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

POC Cholesterol Professional Testing

Table 11-3: POC Lipid Professional Testing Market Analysis, 2016-2021 (in millions of dollars at the manufacturer’s level)

COMPETITIVE ANALYSIS

Table 11-4: Global POC Cholesterol Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 11-2: Global POC Lipid Testing Manufacturers by Percent, 2017

12: POC CANCER TUMOR MARKER TESTING

PRODUCTS

Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications

MARKET SIZE AND GROWTH

Table 12-2: Global POC Cancer Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 12-1: POC Cancer Tumor Marker Testing Regional Market Analysis 2017

COMPETITIVE ANALYSIS

Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 12-2: Global POC Cancer Testing Manufacturers by Percent, 2017

13: POC URINE STRIP TESTING

PRODUCTS

MARKET SIZE AND GROWTH

Table 13-1: Global POC Urine Strip Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 13-1: POC Urine Strip Testing Regional Market Analysis 2017

POC Urine Strip Self-Testing

Table 13-2: POC Urine Strip Self-Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

POC Urine Test Strip Professional Testing

Table 13-3: POC Urine Strip Porfessional Testing Market Analysis, 2017-2022 (in millions of dollars at the manufacturer’s level)

COMPETITIVE ANALYSIS

Table 13-4: Global POC Urine Strip Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 13-2: Global POC Urine Strip Testing Manufacturers by Percent, 2017

14: MISCELLANEOUS POC TESTING

MICROBIOLOGY

TSH

ALLERGY

AUTOIMMUNE

OTHERS

MARKET SIZE AND GROWTH

Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 14-1: POC Miscellaneous Testing Regional Market Analysis 2017

15: ISSUES AND TRENDS

OVERVIEW

WEARABLES

Table 15-1: Selected Wearable Devices

PATIENT-CENTERED HEALTHCARE

BREATH TEST ADVANCES

Table 15-2: Selected Disease Markers in Exhaled Breath

REGULATORY HURDLES

REIMBURSEMENT CHALLENGES

COMPETITION

POC AND MOLECULAR DIAGNOSTICS

Table 15-3: Market Available Molecular POC Diagnostic Platforms

POC AND BIOSENSORS AND MICROFLUIDICS

Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2017

Table 15-5: Selected Biochip and Biosensor Players, 2017

POC CONNECTIVITY

THE EMERGENCE OF NON-INVASIVE TECHNOLOGIES

Saliva and Swab

Optical Techniques

16: TOTAL GLOBAL POC TESTING MARKET AND COMPETITOR ANALYSIS

MARKET OVERVIEW

Table 16-1: Global POC Test Market, 2015-2022 (in millions % at manufacturer level)

MARKET ANALYSIS BY PRODUCT CATEGORIES

Table 16-2: Global POC Testing Market Analysis by Product Category, 2017 (in millions $)

MARKET ANALYSIS BY SUBCATEGORY

POC Professional Testing

Table 16-3: Global POC Professional Testing Market Analysis by Product Subcategory, 2017 (in millions$)

POC Self-Testing

Table 16-4: Global POC Self-Testing Market Analysis by Product Category, 2017 (in millions$)

MARKET ANALYSIS BY COUNTRY

United States

Europe

Japan

Rest of World

Table 16-5: Global POC Testing Analysis by Region/Country, 2017 (in millions $)

Figure 16-1: Global POC Testing Market Analysis Percent by Region/Country, 2017

Table 16-6: Global POC Testing Market Analysis by European Region, 2017 (in millions $)

Figure 16-2: Global POC Testing Market Analysis by European Region, 2017

Table 16-7: Global POC Testing Market Analysis by Rest of World Region/Country, 2017 (in millions $)

Figure 16-3: Global POC Testing Market Analysis by Rest of World Region/Country, 2017

COMPETITIVE ANALYSIS

Table 16-8: Global POC Testing Market Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 16-4: Global POC Testing Market Share by Leading Suppliers, 2016

17: CORPORATE PROFILES

OVERVIEW

1 STEP DETECT ASSOCIATES, LLC

Table 17-1: 1-Step Detect Associates Corporate Summary

Company Overview

Products

ABAXIS, INC.

Table 17-2: Abaxis Corporate Summary

Company Overview

Products

Performance Review

Table 17-3: Abraxis Revenues 2015-2017 (in thousands $)

ABBOTT LABORATORIES

Table 17-4: Abbott Corporate Summary

Company Overview

Product

Performance Review

Table 17-5: Abbott Revenues 2015-2017 (in millions $)

ACCESS BIO, INC.

Table 17-6: Access Bio Corporate Summary

Company Overview

Products

ABINGDON HEALTH, LTD.

Table 17-7: Abingdon Health Corporate Summary

Company Overview

Products

ACCUBIOTECH CO, LTD.

Table 17-8: AccuBioTech Corporate Summary

Company Overview

Products

ACCUTECH, LLC

Table 17-9: Accutech Corporate Summary

Company Overview

Products

ACCRIVA DIAGNOSTICS

Table 17-10: Accriva Diagnostics Corporate Summary

Company Overview

Products

ACON LABORATORIES, INC

Table 17-11: ACON Laboratories Corporate Summary

Company Overview

Products

AERSCHER DIAGNOSTICS, LLC

Table 17-12: Aerscher Diagnostics Corporate Summary

Company Overview

Products

AKERS BIOSCIENCES, INC.

Table 17-13: Akers Biosciences Corporate Summary

Company Overview

Products

Company Financials

Table 17-14: Akers Corporation Revenue (2014-2017) ($ millions)

ALERE INC

Table 17-15: Alere Corporate Summary

Company Overview

Product

Performance Review

Table 17-16: Alere Revenue (2014-2017) ($ millions)

ALFA SCIENTIFIC DESIGNS, INC

Table 17-17: Alfa Scientific Corporate Summary

Company Overview

Products

AMERICAN BIO MEDICA CORPORATION

Table 17-18: American Bio Medica Corporate Summary

Company Overview

Products

Performance Review

Table 17-19: American Bio Medica Corporation Revenue (2014-2017) ($ millions)

AMNISURE INTERNATIONAL

Table 17-20: Amnisure International Corporate Summary

Company Overview

Products

AQUILA DIAGNOSTIC SYSTEMS, INC

Table 17-21: Aquila Diagnostic Systems Summary

Company Overview

Products

ARLINGTON SCIENTIFIC, INC.

Table 17-22: Arlington Scientific Corporate Summary

Company Overview

Products

ARKRAY

Table 17-23: Arkay Corporate Summary

Company Overview

Products

ARTRON LABORATORIES, INC

Table 17-24: Artron Laboratories Corporate Summary

Company Overview

Products

ATLAS GENETICS LTD.

Table 17-25: Atlas Genetics Corporate Summary

Company Overview

Products

ATLAS LINK BIOTECH CO., LTD

Table 17-26: Atlas Link Biotech Corporate Summary

Company Overview

Products

ATIVA MEDICAL CORPORATION

Table 17-27: Ativa Medical Corporate Summary

Company Overview

Products

AUDIT DIAGNOSTICS

Table 17-28: Audit Diagnostics Corporate Summary

Company Overview

Products

AUTOBIO DIAGNOSTICS CO., LTD

Table 17-29: Autobio Corporate Summary

Company Overview

Products

AUGURIX DIAGNOSTIC

Table 17-30: Augurix Diagnostic Corporate Summary

Company Overview

Products

AXXIN

Table 17-31: Axxin Corporate Summary

Company Overview

Products

BECKMAN COULTER, INC

Table 17-32: Beckman Coulter Corporate Summary

Company Overview

Products

BECTON DICKINSON (BD)

Table 17-33: BD Corporate Summary

Company Overview

Products

Company Financials

Table 17-34: BD Corporation Revenue (2014-2017) ($ millions)

BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.

Table 17-35: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary

Company Overview

Products

BHAT BIO-TECH INDIA PRIVATE LTD. (BBI)

Table 17-36: Bhat Bio-Tech India Private Corporate Summary

Company Overview

Products

BIOLYTICAL LABORATORIES

Table 17-37: bioLytical Laboratories Corporate Summary

Company Overview

Products

BIOMERICA, INC.

Table 17-38: Biomerica Corporate Summary

Company Overview

Products

Company Financials

Table 17-39: Biomerica Corporation Revenue (2014-2017) ($ millions)

BIORACLE LIMITED

Table 17-40: biOracle Corporate Summary

Company Overview

Products

BIOMEDOMICS, INC

Table 17-41: BioMedomics Corporate Summary

Company Overview

Products

BIOMEME, INC

Table 17-42: Biomeme Corporate Summary

Company Overview

Products

BIOMERIEUX SA

Table 17-43: bioMerieux SA Corporate Summary

Company Overview

Products

Company Financials

Table 17-44: bioMerieux Revenues (2014-2017) ($ millions)

BIOPHOR DIAGNOSTICS, INC

Table 17-45: Biophor Diagnostics Corporate Summary

Company Overview

Products

BIO-RAD LABORATORIES INC

Table 17-46: Bio-Rad Labs Corporate Summary

Company Overview

Products

Company Financials

Table 17-47: Biomerica Corporation Revenue (2014-2017) ($ millions)

BIOSCAN SCREENING SYSTEMS, INC.

Table 17-48: Bioscan Screening Systems Corporate Summary

Company Overview

Products

BIOTRON DIAGNOSTICS, INC.

Table 17-49: Biotron Diagnostics Corporate Summary

Company Overview

Products

BIOSENSIA

Table 17-50: Biosensia Corporate Summary

Company Overview

Products

BODITECH MED INC

Table 17-51: Rheonix Corporate Summary

Company Overview

Products

BOSON BIOTECH CO. LTD

Table 17-52: Boson Biotech Corporate Summary

Company Overview

Products

BTNX

Table 17-53: BNTX Corporate Summary

Company Overview

Products

CALYPTE BIOMEDICAL CORPORATION

Table 17-54: Calypte Biomedical Corporate Summary

Company Overview

Products

CARE PRODUCTS, INC.

Table 17-55: CARE Products Corporate Summary

Company Overview

Products

CEPHEID, INC

Table 17-56: Cephid Corporate Summary

Company Overview

Products

Performance Review

Table 17-57: Cepheid Revenues (2014-2017) ($ millions)

CHEMBIO DIAGNOSTIC SYSTEMS, INC.

Table 17-58: Chembio Diagnostic Corporate Summary

Company Overview

Products

Performance Review

Table 17-59: Chembio Diagnostics Revenues (2014-2017) ($ millions)

CHURCH & DWIGHT CO. INC

Table 17-60: Church & Dwight Corporate Summary

Company Overview

Products

Performance Review

Table 17-61: Church and Dwight Revenues (2014-2017) ($ millions)

CLARITY DIAGNOSTICS, LLC

Table 17-62: Clarity Diagnostics Corporate Summary

Company Overview

Products

CONFIRM BIOSCIENCES

Table 17-63: Confirm Biosciences Corporate Summary

Company Overview

Products

CTK BIOTECH, INC.

Table 17-64: CTK Biotech Corporate Summary

Company Overview

Products

DAKTARI DIAGNOSTICS

Table 17-65: Daktari Diagnostics Corporate Summary

Company Overview

Products

DANAHER CORPORATION

Table 17-66: Danaher Corporation Summary

Company Overview

Products

Company Financials

Table 17-67: Danaher Revenues (2014-2017) ($ millions)

DEXCOM, INC

Table 17-68: Dexcom Corporate Summary

Company Overview

Products

Performance Review

Table 17-69: Dexcom Revenues (2014-2017) ($ millions)

DIALAB GMBH

Table 17-70: DIALAB Corporate Summary

Company Overview

Products

DIASYS DIAGNOSTIC SYSTEMS GMBH

Table 17-71: DiaSys Diagnostic Systems Corporate Summary

Company Overview

Products

DIAXOHIT

Table 17-72: Diaxohit Corporate Summary

Company Overview

Products

DIAZYME LABORATORIES, INC.

Table 17-73: Diazyme Laboratories Corporate Summary

Company Overview

Products

DNA ELECTRONICS LTD. (DNAE)

Table 17-74: DNA Electronics Corporate Summary

Company Overview

Products

DRAGERWERK AG & CO. KGAA

Table 17-75: Dragerwerk Corporate Summary

Company Overview

Products

Company Financials

Table 17-76: Dexcom Revenues (2014-2017) ($ millions)

  1. FOOKE-ACHTERRATH LABORATOREN GMBH

Table 17-77: Dr. Fooke-Achterrath Laboratorien Corporate Summary

Company Overview

Products

DRG INTERNATIONAL, INC.

Table 17-78: DRG International Corporate Summary

Company Overview

Products

EIKEN CHEMICAL CO LTD.

Table 17-79: Eiken Chemical Corporate Summary

Company Overview

Products

Performance Review

Table 17-80: Eiken Chemical Revenues (2014-2017) ($ millions)

EKF DIAGNOSTICS HOLDINGS PLC

Table 17-81: EKF Diagnostics Corporate Summary

Company Overview

Products

Performance Review

Table 17-82: Eiken Chemical Revenues (2014-2017) ($ billions)

ELITECHGROUP, INC.

Table 17-83: ELITechGroup Corporate Summary

Company Overview

Products

ENTERIX, INC

Table 17-84: Enterix Corporate Summary

Company Overview

Products

ENTOPSIS

Table 17-85: Entopsis Corporate Summary

Company Overview

Products

EUROLYSER DIAGNOSTICA GMBH

Table 17-86: Eurolyser Diagnostica Corporate Summary

Company Overview

Products

EY LABORATORIES

Table 17-87: EY Laboratories Corporate Summary

Company Overview

Products

EXALENZ BIOSCIENCE LTD.

Table 17-88: Exalenz Bioscience Corporate Summary

Company Overview

Products

Performance Review

Table 17-89: Exalenz Bioscience Revenues (2014-2017) ($ millions)

FABPULOUS B.V.

Table 17-90: FABPulous Corporate Summary

Company Overview

Products

FIO CORPORATION

Table 17-91: Fio Corporate Summary

Company Overview

Products

FIRST CHECK DIAGNOSTICS LLC

Table 17-92: First Check Diagnostics Corporate Summary

Company Overview

Products

GENBIO

Table 17-93: GenBio Corporate Summary

Company Overview

Products

GENEDRIVE PLC

Table 17-94: Genedrive Corporate Summary

Company Overview

Products

Performance Review

Table 17-95: Genedrive Revenues (2014-2017) ($ thousands)

GETEIN BIOMEDICAL, INC.

Table 17-96: GeTein Corporate Summary

Company Overview

Products

GLYSBY SNC

Table 17-97: GlysBy Corporate Summary

Company Overview

Products

HELENA LABORATORIES

Table 17-98: Helena Laboratories Corporate Summary

Company Overview

Products

HEMA DIAGNOSTIC SYSTEMS, LLC

Table 17-99: Hema Diagnostics Systems Corporate Summary

Company Overview

Products

HEMOSURE, INC.

Table 17-100: Hemosure Corporate Summary

Company Overview

Products

HORBIA, LTD.

Table 17-101: HORBIA Corporate Summary

Company Overview

Products

Performance Review

Table 17-102: HORIBA Revenues (2014-2017) ($ thousands)

IMMUNOSCIENCES LAB, INC.

Table 17-103: Immunosciences Lab Corporate Summary

Company Overview

Products

IMMUNOSTICS, INC

Table 17-104: Immunostics Corporate Summary

Company Overview

Products

INSILIXA, INC

Table 17-105: InSilixa Corporate Summary

Company Overview

Products

INSTRUMENTATION LABORATORY

Table 17-106: Instrumentation Laboratory Corporate Summary

Company Overview

Products

JAL INNOVATIONS PTE LTD

Table 17-107: JAL Innovations Corporate Summary

Company Overview

Products

JANT PHARMACAL CORPORATION

Table 17-108: Jant Pharmacal Corporate Summary

Company Overview

Products

  1. MITRA & CO PVT. LTD

Table 17-109: J Mitra Corporate Summary

Company Overview

Products

LAMDAGEN CORPORATION

Table 17-110: LamdaGen Corporate Summary

Company Overview

Products

LIFESCAN, INC

Table 17-111: LifeScan Corporate Summary

Company Overview

Products

Performance Review

Table 17-112: LifeScan Revenues (2014-2017) ($ thousands)

LIFESIGN, LLC

Table 17-113: LifeSign Corporate Summary

Company Overview

Products

MACHEREY-NAGEL GMBH & CO. KG

Table 17-114: Macherey-Nagel Corporate Summary

Company Overview

Products

MAGNASENSE TECHNOLOGIES

Table 17-115: Magnasense Technologies Corporate Summary

Company Overview

Products

MBIO DIAGNOSTICS, INC

Table 17-116: Mbio Diagnostics Corporate Summary

Company Overview

Products

MEDIX BIOCHEMICA

Table 17-117: Medix Biochemica Corporate Summary

Company Overview

Products

MEDMIRA, INC

Table 17-118: MedMira Corporate Summary

Company Overview

Products

Performance Review

Table 17-119: Medmira Revenues (2014-2017) ($ thousands)

MEDTRONIC

Table 17-120: Medtronic Corporate Summary

Company Overview

Products

Performance Review

Table 17-121: Medtronic Revenues (2014-2017) ($ thousands)

  1. MENARINI DIAGNOSTICS SRL.

Table 17-122: Menarini Diagnostics Corporate Summary

Company Overview

Products

MERIDIAN BIOSCIENCE, INC

Table 17-123: Meridian BioScience Corporate Summary

Company Overview

Products

Performance Review

Table 17-124: Meridian Bioscience (2014-2017) ($ millions)

METAARA MEDICAL TECHNOLOGIES, INC

Table 17-125: Metaara Medical Technologies Corporate Summary

Company Overview

MICRONICS, INC

Table 17-126: Micronics Corporate Summary

Company Overview

Products

NANO-DITECH CORPORATION

Table 17-127: Nano-Ditech Corporate Summary

Company Overview

Products

NOBLE MEDICAL, INC

Table 17-128: Nobel Medical Corporate Summary

Company Overview

Products

NOVA BIOMEDICAL, CORP.

Table 17-129: Nova Biomedical Corporate Summary

Company Overview

Products

OASIS DIAGNOSTICS CORPORATION

Table 17-130: Oasis Diagnostics Corporate Summary

Company Overview

Products

OPERON

Table 17-131: Operon Corporate Summary

Company Overview

Products

OPKO HEALTH, INC

Table 17-132: OPKO Health Corporate Summary

Company Overview

Products

Performance Review

Table 17-133: OPKO Health Revenues (2014-2017) ($ millions)

OPTI MEDICAL SYSTEMS, INC

Table 17-134: OPTI Medical Corporate Summary

Company Overview

Products

ORASURE TECHNOLOGIES, INC.

Table 17-135: OraSure Technologies Corporate Summary

Company Overview

Products

Performance Review

Table 17-136: OraSure Revenues (2014-2017) ($ millions)

POLYMED THERAPEUTICS INC.

Table 17-137: Polymed Therapeutics Corporate Summary

Company Overview

Products

POLYMEDCO, INC

Table 17-138: Polymedco Corporate Summary

Company Overview

Products

POLYMER TECHNOLOGIES, INC (PTS DIAGNOSTICS)

Table 17-139: Polymer Technologies Corporate Summary

Company Overview

Products

PREVENTIS GMBH

Table 17-140: Preventis Corporate Summary

Company Overview

Products

PRINCETON BIOMEDITECH CORPORATION

Table 17-141: Princeton Biomeditech Corporate Summary

Company Overview

Products

QUANTUMDX GROUP LIMITED

Table 17-142: QuantuMDx Group Corporate Summary

Company Overview

Products

QUIDEL CORPORATION

Table 17-143: Quidel Corporate Summary

Company Overview

Products

Performance Review

Table 17-144: Quidel Revenues (2014-2017) ($ millions)

RADIOMETER MEDICAL A/S

Table 17-145: Radiometer Medical Corporate Summary

Company Overview

Products

Performance Review

Table 17-146: Radiometer (2014-2017) ($ millions)

RENESA UG

Table 17-147: RENESA UG Corporate Summary

Company Overview

Products

RESPONSE BIOMEDICAL CORP

Table 17-148: Response Biomedical Corporate Summary

Company Overview

Products

RESZON DIAGNOSTICS INTERNATIONAL SDN. BHD.

Table 17-149: Reszon Diagnostics Corporate Summary

Company Overview

Products

RHEONIX, INC

Table 17-150: Rheonix Corporate Summary

Company Overview

Products

ROCHE DIAGNOSTIC CORPORATION

Table 17-151: Roche Diagnostic Corporate Summary

Company Overview

Products

Performance Review

Table 17-152: Roche Diagnostics (2014-2017) ($ millions)

SAMSUNG HEALTHCARE

Table 17-153: Samsung Healthcare Corporate Summary

Company Overview

Products

SAVYON DIAGNOSTICS

Table 17-154: Savyon Diagnostics Corporate Summary

Company Overview

Products

SEKISUI DIAGNOSTICS

Table 17-155: Sekisui Diagnostics Corporate Summary

Company Overview

Products

SIEMENS HEALTHINEERS GMBH

Table 17-156: Siemens Healthineers Corporate Summary

Company Overview

Products

Performance Review

Table 17-157: Siemens Healthineers (2014-2017) ($ millions)

SILOAM BIOSCIENCES, INC

Table 17-158: Siloam Biosciences Summary

Company Overview

Products

SPECTRAL MEDICAL, INC

Table 17-159: Spectral Medical Summary

Company Overview

SYSMEX CORPORATION

Table 17-160 Sysmex Corporate Summary

Company Overview

Products

Performance Review

Table 17-161: Sysmex (2014-2017) ($ millions)

TECHLAB, INC.

Table 17-162: TECHLAB Corporate Summary

Company Overview

Products

TECO DIAGNOSTICS

Table 17-163: Teco Diagnostics Corporate Summary

Company Overview

Products

TRINITY BIOTECH PLC

Table 17-164: Trinity Biotech Corporate Summary

Company Overview

Products

Performance Review

Table 17-165: Trinity Biotech Revenue (2014-2017) ($ millions)

TRIVIDIA HEALTH

Table 17-166 Trividia Health Corporate Summary

Company Overview

Products

TULIP DIAGNOSTICS LTD

Table 17-167: Tulip Diagnostics Corporate Summary

Company Overview

Product

VEREDUS LABORATORIES PTE LTD

Table 17-168: Veredus Labs Corporate Summary

Company Overview

Products

VIRCELL

Table 17-169: Vircell Corporate Summary

Company Overview

Products

WAMA DIAGNOSTICA

Table 17-170: WAMA Diagnostica Corporate Summary

Company Overview

Products

WAVE 80 BIOSCIENCES

Table 17-171: Wave 80 Biosciences Corporate Summary

Company Overview

Products

WERFEN

Table 17-172: Werfen Corporate Summary

Company Overview

XAGENIC

Table 17-173 Xagenic Corporate Summary

Company Overview

Products

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Cell-Based Diagnostics: Technology, Applications, and Markets

    $3,500.00 – $7,000.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    $4,500.00 – $9,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
What’s Trending in Monoclonal Antibodies (Market by Structure [Chimeric,...Infectious Disease Diagnostic Testing: World Market Analysis of TB, Flu, HIV,...
Scroll to top